InMed Pharmaceuticals Inc. (INM) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    InMed Pharmaceuticals Inc...

    NASDAQ: INM · Real-Time Price · USD
    2.29
    0.03 (1.33%)
    At close: Oct 03, 2025, 3:59 PM
    2.23
    -2.62%
    After-hours: Oct 03, 2025, 04:22 PM EDT

    InMed Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is July - June.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Jun 30, 2025 Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
    Revenue
    		 4.94M 6.29M 5.48M 1.4M n/a
    Cost of Revenue
    		 3.24M 4.78M 3.62M 702.87K 197.03K
    Gross Profit
    		 1.71M 1.51M 1.86M 699.85K -197.03K
    Operating Income
    		 -7.7M -11.12M -11.1M -17.76M -9.92M
    Interest Income
    		 156.53K 721.97K 652.37K 123.72K 16.02K
    Pretax Income
    		 -8.16M -10.49M -10.51M -23.95M -10.2M
    Net Income
    		 -8.16M -10.5M -10.53M -23.95M -10.2M
    Selling & General & Admin
    		 6.56M 7.18M 7.75M 8.84M 4.48M
    Research & Development
    		 2.85M 5.15M 4.94M 9.38M 5.34M
    Other Expenses
    		 n/a 300.33K 267.93K 239.05K 120.87K
    Operating Expenses
    		 9.41M 12.63M 12.96M 18.46M 9.94M
    Interest Expense
    		 373.11K n/a n/a n/a 360.35K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a
    Cost & Expenses
    		 12.64M 17.41M 16.58M 19.16M 9.94M
    Income Tax Expense
    		 n/a 9.71K 17.35K n/a 360.35K
    Shares Outstanding (Basic)
    		 975.99K 762.11K 244.54K 56.08K 26.88K
    Shares Outstanding (Diluted)
    		 975.99K 762.11K 244.85K 56.08K 26.88K
    EPS (Basic)
    		 -8 -13.77 -43.05 -427.09 -379.48
    EPS (Diluted)
    		 -8 -13.77 -43 -427.03 -379.47
    EBITDA
    		 -7.7M -10.3M -10.31M -17.1M -9.8M
    EBIT
    		 -7.92M -11.12M -11.1M -17.76M -12.29M
    Depreciation & Amortization
    		 212.79K 826.76K 789.55K 658.96K 197.03K

    Add to Watchlist